Page
%P
-
Article
Drug Survival of Interleukin (IL)‑17 and IL‑23 Inhibitors for the Treatment of Psoriasis: A Retrospective Multi‑country, Multicentric Cohort Study
Drug survival, defined as the length of time from initiation to discontinuation of a given therapy, allows comparisons between drugs, helps to predict patient’s likelihood of remaining on a specific treatment,...
-
Article
Open AccessImpact of Body Mass Index on the Efficacy of Biological Therapies in Patients with Psoriasis: A Real-World Study
The efficacy of biological therapies used for the treatment of chronic plaque psoriasis can be influenced by numerous variables including body mass index (BMI).